Advanced Biomed Inc. Common Stock
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ADVB research report →
About the company
Advanced Biomed Inc. functions as an investment holding company, primarily dedicated to the research and development of microfluidic biochip technologies. Based in Taiwan, the company leverages these innovations to enhance precision oncology, spanning cancer detection, diagnosis, and treatment.
- CEO
- Yi Lu
- IPO
- 2025
- Employees
- 40
- HQ
- New York City, NY, US
Price Chart
- Market Cap
- $5.40M
- P/E
- -9.46
- P/S
- 0.00
- P/B
- 22.26
- EV/EBITDA
- -5.32
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -65.06%
- ROIC
- -332.17%
- Revenue
- $0 · 0.00%
- Net Income
- $-101,524 · 96.35%
- EPS
- $-0.09 · -16.09%
- Op Income
- $-94,112
- FCF YoY
- 91.71%
- 52W High
- $18.20
- 52W Low
- $3.61
- 50D MA
- $4.87
- 200D MA
- $6.41
- Beta
- 0.53
- Avg Volume
- 435.25K
Get TickerSpark's AI analysis on ADVB
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jan 3, 05 | CAPPELLO ALEXANDER L | other | 25,000 |
| Mar 31, 04 | CAPPELLO ALEXANDER L | other | 0 |
| Mar 31, 04 | CAPPELLO ALEXANDER L | other | 155,945 |
| Dec 31, 03 | CAPPELLO ALEXANDER L | other | 12,948 |
| Dec 31, 03 | CAPPELLO ALEXANDER L | other | 30,000 |
Our ADVB coverage
Recent articles, reports, and earnings notes.
No research on ADVB yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate ADVB report →Similar companies
Peers in the same neighborhood.